Literature DB >> 2752891

Abnormal glucose tolerance in the Maltese. A population-based longitudinal study of the natural history of NIDDM and IGT in Malta.

A G Schranz1.   

Abstract

A population-based longitudinal study of abnormal glucose tolerance in the adult Maltese, carried out within the WHO-assisted National Diabetes Programme, has recently been completed. During the 6-year interval abnormal as compared to normal glucose tolerance was found to be related to a significantly higher mortality: the age-adjusted relative risks of death were 3.3 times in diabetic females and greater than 2 times in IGT and diabetic males. In the repeat epidemiological survey 1422 subjects (66.8% of the initial sample) were reinvestigated with the oral GTT being interpreted according to WHO's 1985 recommendations. The age-standardised prevalence rates, in the 35-69-year-old males and females, were respectively 12.89% and 13.24% for IGT and 9.07% and 10.77% for diabetes. These gradually increased after age 40, IGT peaking in the 60+ year groups and diabetes 10 years later. Heredity (especially diabetes in close relatives) seemed a major influence, whilst excess body weight appeared the more important associated environmental factor. The incidence levels (% per annum) of diabetes during the interval were 0.71 for normoglycaemics and 5.1 for IGTs; this seven times higher risk in the latter was slightly lower in females than males, but significantly higher in the less than 60-year-olds compared to older subjects. Of the initial IGTs 36% remained IGT and 33% reverted to normal glucose tolerance, whilst 11% of the initial normoglycaemics deteriorated to IGT. The determinants more strongly influencing worsening of glucose tolerance were age (greater than 50 years), baseline glycaemia (fasting greater than 5.5 mmol/l and a 2-h post-load glycaemia greater than 9.5 mmol/l) and initial body mass index (greater than 27 kg/m2). In conclusion the data permit a better insight into the natural history of, and risk factors for, disturbed glucose tolerance in this community.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752891     DOI: 10.1016/0168-8227(89)90038-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

Review 1.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

2.  Recent trends in the epidemiology of diabetes mellitus in European and Mediterranean countries.

Authors:  L Papoz
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

3.  Relationship between anthropometric indices of body fat distribution and basal energy metabolism in healthy Maltese women.

Authors:  E Pullicino; C Copperstone; L Luzi; G McNeill; M Elia
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

4.  Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies.

Authors:  S L Edelstein; W C Knowler; R P Bain; R Andres; E L Barrett-Connor; G K Dowse; S M Haffner; D J Pettitt; J D Sorkin; D C Muller; V R Collins; R F Hamman
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

5.  Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study.

Authors:  M P Garancini; G Calori; G Ruotolo; E Manara; A Izzo; E Ebbli; A M Bozzetti; L Boari; P Lazzari; G Gallus
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  A population-based prevalence survey of known diabetes mellitus in northern Italy based upon multiple independent sources of ascertainment.

Authors:  G Bruno; G Bargero; A Vuolo; E Pisu; G Pagano
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

7.  Progression to impaired glucose regulation and diabetes in the population-based Inter99 study.

Authors:  Susanne Engberg; Dorte Vistisen; Cathrine Lau; Charlotte Glümer; Torben Jørgensen; Oluf Pedersen; Knut Borch-Johnsen
Journal:  Diabetes Care       Date:  2008-12-29       Impact factor: 19.112

8.  LC-HRMS based approach to identify novel sphingolipid biomarkers in breast cancer patients.

Authors:  Priyanka Bhadwal; Divya Dahiya; Dhananjay Shinde; Kim Vaiphei; Raviswamy G H Math; Vinay Randhawa; Navneet Agnihotri
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

9.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.